Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

NCT01155817 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Bone Marrow Transplant Failure
Lymphoma, Non-Hodgkin
Lymphoma, T-Cell, Peripheral

Interventions

DRUG: Nilotinib

Sponsor

Stanford University

Collaborators

[object Object]